Macrogenics (MGNX) Change in Account Payables (2012 - 2017)
Macrogenics (MGNX) reported Change in Account Payables of $197000.0 for Q2 2017, up 496.97% year-over-year from $33000.0 in Q2 2016, and up 108.86% quarter-over-quarter from -$2.2 million in Q1 2017.
Macrogenics (MGNX) Change in Account Payables (2012 - 2017) Analysis & Trends
Macrogenics (MGNX) has 6 years of Change in Account Payables data on file, last reported at $197000.0 in Q2 2017.
- Change in Account Payables for Q2 2017 came in at $197000.0, up 496.97% year-over-year; the trailing twelve-month figure through Jun 2017 was $561000.0 (up 179.91% YoY), and the FY2025 annual result was -$280000.0, up 81.7% from the prior year.
- Change in Account Payables grew to $197000.0 in Q2 2017 per MGNX's latest filing, from -$2.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.4 million in Q4 2016 and troughed at -$2.7 million in Q4 2014.
- A 5-year average of -$112611.1 and a median of -$96000.0 in 2015 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 496.97% in 2017 and fell as far as 472.94% in 2017.
- A 5-year view of Change in Account Payables shows it stood at $1.4 million in 2013, then sank by 298.32% to -$2.7 million in 2014, then jumped by 61.93% to -$1.0 million in 2015, then jumped by 328.5% to $2.4 million in 2016, then plunged by 91.67% to $197000.0 in 2017.
- Business Quant data shows MGNX's Change in Account Payables at $197000.0 in Q2 2017, -$2.2 million in Q1 2017, and $2.4 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 197,000.00 |
| Jun 30, 2017 | 197,000.00 |
| Mar 31, 2017 | -2.22 Mn |
| Mar 31, 2017 | -2.22 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Sep 30, 2016 | 222,000.00 |
| Sep 30, 2016 | 222,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Dec 31, 2015 | -1.04 Mn |
| Dec 31, 2015 | -1.04 Mn |
| Sep 30, 2015 | 688,000.00 |
| Sep 30, 2015 | 688,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | -225,000.00 |
| Mar 31, 2015 | -225,000.00 |